anthropolo.gyYour collection ↗
Follow the financing

Funding events.

Explore distinct financings and the sources that report them. One event may have several investor records; it can also be recorded before its investors are identified.

Source assertions, automatically extracted reports, and discovery leads retain separate labels. Investor associations and unclassified leads are excluded from the reported financing total. Filing amounts are issuer-reported.

Investor relationships ↗Investment partners ↗Sources and research references ↗
Clear filters

Recipient: Spearhead Bio, Inc. ↗

1–1 of 1 matching financing events

  1. Spearhead Bio, Inc. ↗

    Spearhead Bio, Inc. — reported private financing

    Issuer-reported filingSEC filings · issuer-reportedFinancing event

    The issuer reports these values in its filing. They are not SEC verification of the financing.

    First sale · issuer-reported
    Financing
    Type not specified
    Closing status
    Not specified
    Reported proceeds
    USD 1,200,000
    Offering target
    USD 1,750,000

    Source context: Issuer-reported Form D facts, not verified by the SEC. Reported proceeds are securities sold as of the selected filing, not necessarily a final round size. Offering targets are separate. Investor identities, lead roles and funding stages are not inferred.

    Reported proceeds are sales reported as of the filing. An offering target does not establish that the offering was completed or fully funded.

    Event reference: sec-form-d:0002057359:2026-06-18